Moexipril

DRUG2 trials

Sponsors

Novartis Pharma AG, Mayo Clinic

Conditions

Heart FailurePrimary Biliary Cirrhosis

Phase 2

Moexipril for Primary Biliary Cirrhosis

CompletedNCT00588302

Mayo ClinicPrimary Biliary Cirrhosis

Start: 2003-06-30End: 2007-06-30Updated: 2011-05-23

A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure

CompletedCTIS2023-504678-39-00

Novartis Pharma AGHeart Failure

Start: 2024-03-13End: 2024-11-08Target: 424Updated: 2024-11-08